{{short description|Hepatocellular adenoma (HA) is a rare benign tumor of the liver}}
{{distinguish|Hepatocellular carcinoma}}
{{Infobox medical condition (new)
| name            = Hepatocellular adenoma
| image           = Hepatic_adenoma_low_mag.jpg
| caption         = [[Micrograph]] of a '''hepatic adenoma''' (bottom of image). [[H&E stain]]
|
| pronounce       = 
| field           = 
| synonyms        = 
| symptoms        =
| complications   =
| onset           =
| duration        =
| types           =
| causes          =
| risks           =
| diagnosis       =
| differential    =
| prevention      =
| treatment       =
| medication      =
| prognosis       =
| frequency       =
| deaths          =
}}
'''Hepatocellular adenoma''' (also known as '''hepatic adenoma''' or '''hepadenoma''') is a rare, benign [[liver]] tumor. It most commonly occurs in people with elevated systemic levels of [[estrogen]], classically in women taking estrogen-containing oral contraceptive medication.<ref>{{cite journal|year=1979|title=Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.|journal=JAMA|volume=242|issue=7|pages=644–8|doi=10.1001/jama.242.7.644|pmid=221698|vauthors=Rooks J, Ory H, Ishak K, Strauss L, Greenspan J, Hill A, Tyler C}}</ref>

==Signs and symptoms==
About 25–50% of hepatic adenomas cause pain in the [[right upper quadrant]] or [[epigastric]] region of the abdomen.<ref name="urlHepatocellular Adenoma: eMedicine Gastroenterology">{{cite web|url=http://emedicine.medscape.com/article/170205-overview|title=Hepatocellular Adenoma: eMedicine Gastroenterology|date=14 June 2021 }}</ref> Since hepatic adenomas can be large (8–15&nbsp;cm), patients may notice a palpable mass. However, hepatic adenomas are usually asymptomatic, and may be discovered [[Incidentaloma|incidentally]] on imaging ordered for some unrelated reason.<ref name="urlHepatocellular Adenoma: eMedicine Gastroenterology" />  Large hepatic adenomas have a tendency to rupture and bleed massively inside the abdomen. If not treated, there is a 30% risk of bleeding.<ref name="HarrisonsInternal">{{cite book|url=http://www.accessmedicine.com/content.aspx?aID=9116285|title=Harrison's principles of internal medicine|publisher=McGraw-Hill Medical|year=2008|isbn=978-0071466332|edition=17th|location=New York|pages=Chapter 92 (benign liver tumors)|author1=Anthony S. Fauci|author2=Eugene Braunwald|author3=Dennis L. Kasper|author4=Stephen L. Hauser|author5=Dan L. Longo|author6=J. Larry Jameson|author7=Joseph Loscalzo}}</ref> Bleeding may lead to hypotension, [[tachycardia]], and sweating ([[diaphoresis]]).{{cn|date=March 2022}}

Hepatic adenomas are associated with [[glycogen storage diseases]], [[type 1 diabetes]], as well as [[anabolic steroid]] use.

==Diagnosis==
Hepatic adenoma is usually detected by [[Medical imaging|imaging]], typically an ultrasound or CT, as a hyperenhancing liver nodule. Given that several liver tumors appear similarly on these imaging modalities, a multi-phase contrast-enhanced imaging study such as [[CT scan|CT]] or [[Magnetic resonance imaging|MRI]] may be used to provide more information.<ref name="HarrisonsInternal" /><ref>{{cite journal|year=2006|title=Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis.|journal=Eur Radiol|volume=16|issue=9|pages=1873–86|doi=10.1007/s00330-006-0292-4|pmid=16708218|vauthors=Hussain S, van den Bos I, Dwarkasing R, Kuiper J, den Hollander J|s2cid=27821347 }}</ref>  The significance of making a specific diagnosis is that, unlike other benign liver tumors such as hemangioma and focal nodular hyperplasia, hepatic adenomas have a small but meaningful risk of progressing into a [[malignancy]].<ref name=HarrisonsInternal /> Although imaging provides supportive information, a definitive diagnosis of hepatic adenoma requires [[biopsy]] of the tissue.{{cn|date=March 2022}}

=== Radiologic differential diagnosis ===
* [[Echinococcal cyst]]
* Focal [[fatty change]]
* [[Focal nodular hyperplasia]]
* [[Hepatoblastoma]]
* [[Infiltrative liver disease]]
* [[Inflammatory pseudotumor]]
* [[Leiomyosarcoma]]
* [[Lymphoma]]
* [[Nodular regenerative hyperplasia]]

===Subtypes===
Hepatic adenomas may be sub-classified according to morphologic appearance by microscopy, immunohistochemical staining, and genetic mutational analysis:<ref>{{Cite journal|last1=Bioulac-Sage|first1=Paulette|last2=Sempoux|first2=Christine|last3=Balabaud|first3=Charles|date=June 2017|title=Hepatocellular Adenomas: Morphology and Genomics|journal=Gastroenterology Clinics of North America|volume=46|issue=2|pages=253–272|doi=10.1016/j.gtc.2017.01.003|issn=1558-1942|pmid=28506364}}</ref><ref>{{cite journal|last1=Nault|first1=JC|last2=Couchy|first2=G|last3=Balabaud|first3=C|last4=Morcrette|first4=G|last5=Caruso|first5=S|last6=Blanc|first6=JF|last7=Bacq|first7=Y|last8=Calderaro|first8=J|last9=Paradis|first9=V|last10=Ramos|first10=J|last11=Scoazec|first11=JY|last12=Gnemmi|first12=V|last13=Sturm|first13=N|last14=Guettier|first14=C|last15=Fabre|first15=M|last16=Savier|first16=E|last17=Chiche|first17=L|last18=Labrune|first18=P|last19=Selves|first19=J|last20=Wendum|first20=D|last21=Pilati|first21=C|last22=Laurent|first22=A|last23=De Muret|first23=A|last24=Le Bail|first24=B|last25=Rebouissou|first25=S|last26=Imbeaud|first26=S|last27=GENTHEP|first27=Investigators.|last28=Bioulac-Sage|first28=P|last29=Letouzé|first29=E|last30=Zucman-Rossi|first30=J|title=Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.|journal=Gastroenterology|date=March 2017|volume=152|issue=4|pages=880–894.e6|doi=10.1053/j.gastro.2016.11.042|pmid=27939373|url=https://hal.archives-ouvertes.fr/hal-01797602/file/GASTRO-D-16-02075_R1%20submission.pdf|doi-access=free}}</ref><ref>{{Cite journal|last1=Larson|first1=Brent K.|last2=Guindi|first2=Maha|title=A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice|journal=American Journal of Clinical Pathology|language=en|volume=147|issue=6|pages=557–570|doi=10.1093/ajcp/aqx010|pmid=28472207|year=2017|doi-access=free}}</ref>
* '''Inflammatory''' (40%–50%)
* '''HNF1α-inactivated''' (35%–40%)
* '''β-catenin–activated''' - with exon 3 versus exon 7/8 mutation
* '''β-Catenin–activated inflammatory'''  - with exon 3 versus exon 7/8 mutation
* '''Unclassified'''
Although the significance of this categorization is still under research, the subtypes may indicate differential risk of hemorrhage or malignant transformation.{{cn|date=March 2022}}

===Pathologic diagnosis===
[[Image:Hepatic adenoma high mag reticulin.jpg|thumb|right|160px|[[Micrograph]] of a hepatic adenoma demonstrating a regular reticulin scaffold. [[Reticulin]] stain]]
Hepatic adenomas are, typically, well-circumscribed nodules that consist of sheets of [[hepatocyte]]s with a bubbly [[vacuole|vacuolated]] [[cytoplasm]].  The hepatocytes are on a regular reticulin scaffold and less or equal to three cell thick.

The [[histologic]] diagnosis of hepatic adenomas can be aided by [[reticulin]] [[staining]]. In hepatic adenomas, the reticulin scaffold is preserved and hepatocytes do not form layers of four or more hepatocytes, as is seen in [[hepatocellular carcinoma]].

Cells resemble normal hepatocytes and are traversed by blood vessels but lack portal tracts or central veins.
<gallery>

Image:Hepatic adenoma high mag.jpg|Micrograph of hepatic adenoma. [[H&E stain]]
Image:Hepatic adenoma low mag reticulin.jpg|Micrograph of hepatic adenoma. [[Reticulin]] stain
File:Histopathology of inflammatory hepatocellular adenoma.jpg|Inflammatory hepatocellular adenoma
</gallery>

==Treatment==
Some authors feel that all hepatocellular adenoma should be [[Resection (surgery)|resected]], because of the risk of rupture causing bleeding and because they may contain malignant cells.<ref>{{cite journal |vauthors=Toso C, Majno P, Andres A, Rubbia-Brandt L, Berney T, Buhler L, Morel P, Mentha G | title = Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. | journal = World J Gastroenterol | volume = 11 | issue = 36 | pages = 5691–5 | year = 2005 | pmid = 16237767 | pmc = 4481490 | doi=10.3748/wjg.v11.i36.5691 | doi-access = free }}</ref> Current recommendations are that all hepatic adenomas should be resected, as long as they are surgically accessible and the patient is a reasonable operative candidate.<ref>{{cite journal|last=Cho|first=S|author2=Marsh J |author3=Steel J |title=Surgical management of hepatocellular adenoma: take it or leave it?|journal=Ann Surg Oncol|volume=15|year=2008|issue=10|pages=2795–2803|display-authors=etal|doi=10.1245/s10434-008-0090-0|pmid=18696154|s2cid=207173531}}</ref> Patients with adenomas should avoid oral contraceptives or hormonal replacement therapy.{{cn|date=March 2022}}

Pregnancy could cause the adenoma to grow faster, so patients with hepatic adenomas should avoid pregnancy.<ref>{{cite web|title=Hepatocellular Adenoma Treatment & Management|url=http://emedicine.medscape.com/article/170205-treatment|work=WebMD|publisher=Medscape|access-date=11 July 2012}}</ref>

==Epidemiology==
[[File:Liver tumor types in adults by relative incidence.png|thumb|Liver tumor types by relative incidence in adults in the United States, with hepatocellular adenoma at right.<ref>[https://basicmedicalkey.com/masses-of-the-liver-2/ Table 37.2] in: {{cite book | last=Sternberg | first=Stephen | title=Sternberg's diagnostic surgical pathology | publisher=LWW | publication-place=Place of publication not identified | year=2012 | isbn=978-1-4511-5289-0 | oclc=953861627 }}</ref>]]
The majority of hepatic adenomas arise in women aged 20–40, most of whom use oral contraceptives. Other medications which also alter circulating hormone levels, such as anabolic or androgenic steroids, [[Barbiturates]], [[clomifene]], have also been implicated as risk factors.<ref name="urlHepatocellular Adenoma: eMedicine Gastroenterology" />

Incidence of adenomas may be increased in metabolic diseases, including [[tyrosinemia]] and [[Diabetes mellitus type 1|type 1 diabetes mellitus]], and [[glycogen storage disease]]s (types 1 and 3), as well as in [[Beta thalassemia|beta-thalassemia]] and [[Iron overload|hemochromatosis]].<ref name="urlHepatocellular Adenoma: eMedicine Gastroenterology" />
{{clear}}

==References==
{{Reflist}}

== External links ==
{{Medical resources
| DiseasesDB      = 5726
| ICD10           =
| ICD9            =
| ICDO            = {{ICDO|8170|0}}
| OMIM            =
| MedlinePlus     =
| eMedicineSubj   = med
| eMedicineTopic  = 48
| MeshID          = D018248
| Orphanet        = 54272
}}
* [http://library.med.utah.edu/WebPath/NEOHTML/NEOPL021.html University of Utah—Pathology Images]

{{Solid tumor histology}}
{{Digestive system neoplasia}}

{{DEFAULTSORT:Hepatocellular Adenoma}}
[[Category:Hepatology]]